Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 SEK | -4.17% | -3.55% | -2.61% |
04-10 | Newbury Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 | CI |
02-22 | Newbury Pharmaceuticals Secures SEK9 Million Sales Order | MT |
Sales 2024 * | 38.4M 3.62M 4.94M | Sales 2025 * | 72.4M 6.83M 9.31M | Capitalization | 72.53M 6.84M 9.32M |
---|---|---|---|---|---|
Net income 2024 * | -10M -943K -1.29M | Net income 2025 * | 3M 283K 386K | EV / Sales 2024 * | 2.59 x |
Net Debt 2024 * | 27M 2.55M 3.47M | Net Debt 2025 * | 39M 3.68M 5.01M | EV / Sales 2025 * | 1.54 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 5 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.13% |
1 day | -4.17% | ||
1 week | -3.55% | ||
Current month | -12.32% | ||
1 month | -12.32% | ||
3 months | -36.52% | ||
6 months | -17.86% | ||
Current year | -2.61% |
Managers | Title | Age | Since |
---|---|---|---|
Lars Minor
CEO | Chief Executive Officer | 53 | 20-12-31 |
Christoffer Tell
DFI | Director of Finance/CFO | 37 | 20-12-31 |
Director/Board Member | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 50 | 19-12-31 | |
Director/Board Member | 50 | 19-12-31 | |
Johan Strömqvist
BRD | Director/Board Member | 48 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 2.99 | -4.17% | 25,975 |
24-05-24 | 3.12 | -0.95% | 32,765 |
24-05-23 | 3.15 | -0.32% | 2,262 |
24-05-22 | 3.16 | +7.85% | 40,051 |
24-05-21 | 2.93 | -2.98% | 13,467 |
Delayed Quote Nasdaq Stockholm, May 27, 2024 at 09:55 am
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.61% | 7.11M | |
-11.84% | 8.68B | |
+30.55% | 1.33B | |
-9.90% | 354M | |
+0.57% | 274M | |
+12.22% | 231M | |
-9.17% | 88.72M | |
-45.50% | 84.03M | |
+29.37% | 61.5M |
- Stock Market
- Equities
- NEWBRY Stock